1. Bioinformatics analysis identifies COL1A1, THBS2 and SPP1 as potential predictors of patient prognosis and immunotherapy response in gastric cancer
    Yali Wang et al, 2021, Bioscience Reports CrossRef
  2. Identification of Paxillin as a Prognostic Factor for Glioblastoma via Integrated Bioinformatics Analysis
    Zhehao Huang et al, 2022, BioMed Research International CrossRef
  3. Identification of FABP7 as a Potential Biomarker for Predicting Prognosis and Antiangiogenic Drug Efficacy of Glioma
    Liubing Hou et al, 2022, Disease Markers CrossRef
  4. Quantitative study of bioinformatics analysis on glioma: a bibliometric analysis
    Xiaobing Yang et al, 2023, Frontiers in Oncology CrossRef
  5. Identification of Prognostic Biomarkers of Glioblastoma Based on Multidatabase Integration and Its Correlation with Immune-Infiltration Cells
    Wencong Ding et al, 2022, Journal of Oncology CrossRef
  6. Identification of an Immune-Related Prognostic Risk Model in Glioblastoma
    Zhiying Lin et al, 2022, Frontiers in Genetics CrossRef
  7. TRAF3IP3 promotes glioma progression through the ERK signaling pathway
    Qi Lin et al, 2022, Frontiers in Oncology CrossRef
  8. A pilot radiogenomic study of DIPG reveals distinct subgroups with unique clinical trajectories and therapeutic targets
    Xiaoting Zhu et al, 2021, Acta Neuropathologica Communications CrossRef
  9. Preliminary Exploration of Clinical Efficacy and Pharmacological Mechanism of Modified Danggui-Shaoyao San in the Treatment of Depression in Patients with Chronic Kidney Disease
    Mengdi Xia et al, 2022, Drug Design, Development and Therapy CrossRef
  10. Screening and identification of LMNB1 and DLGAP5, two key biomarkers in gliomas
    Ding Zhou et al, 2021, Bioscience Reports CrossRef
  11. Characterization of the Immune Cell Infiltration Landscape and a New Prognostic Score in Glioblastoma
    Jian Wang et al, 2022, Journal of Healthcare Engineering CrossRef
  12. Characterization of prevalent tyrosine kinase inhibitors and their challenges in glioblastoma treatment
    Mahdie Rahban et al, 2024, Frontiers in Chemistry CrossRef
  13. Novel LncRNA OXCT1-AS1 indicates poor prognosis and contributes to tumorigenesis by regulating miR-195/CDC25A axis in glioblastoma
    Chen Zhong et al, 2021, Journal of Experimental & Clinical Cancer Research CrossRef
  14. The Impact of Epigenetic Modifications on Adaptive Resistance Evolution in Glioblastoma
    Qiong Wu et al, 2021, International Journal of Molecular Sciences CrossRef
  15. Identification of a Novel Risk Model: A Five-Gene Prognostic Signature for Pancreatic Cancer
    Xiaoguang Wang et al, 2022, Evidence-Based Complementary and Alternative Medicine CrossRef
  16. Identification of Influential Genes for Lung Cancer Using Machine Learning Approaches
    Md. Imam Hasan et al, 2022, 2022 4th International Conference on Sustainable Technologies for Industry 4.0 (STI) CrossRef
  17. Machine learning-based immune prognostic model and ceRNA network construction for lung adenocarcinoma
    Xiaoqian He et al, 2023, Journal of Cancer Research and Clinical Oncology CrossRef